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ABSTRACT 
 
Developing Luminescent Nanoprobes for Labeling Focal Adhesion Complex Proteins 
and Performing Combined AFM-TIRF Imaging of These Conjugates. 
(May 2008) 
Bhavik Nathwani, B.E, Saurashtra University 
Chair of Advisory Committee: Dr. Kenith E. Meissner 
 
 Recent progress in the field of semiconductor nanocrystals or Quantum Dots (QDs) 
has seen them find wider acceptance as a tool in biomedical research labs. As produced, 
high quality QDs  synthesized by high temperature organometallic synthesis, are coated 
with a hydrophobic ligand. Therefore, they must be further processed to be soluble in 
water and made biocompatible.  
 A  process to coat the QDs with silk fibroin, a fibrous protein derived from the 
Bombyx mori silk worm, is described. Following the coating process, the characterization 
of size, optical properties and biocompatibility profile of these particle systems is 
described. In addition, conjugation of the silk fibroin coated QDs to different labeling 
proteins such as phalloidin and streptavidin is described. 
 Proteins on the surface of ovarian cancer cells (HeyA8) and of cytoskeletal 
components participating in the formation of focal adhesion complex (FAC), such as F-
actin in endothelial cells (HUVECS) were labeled using the bio-conjugated QDs. 
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 Various imaging techniques such as epi-fluorescence, TIRF and AFM were used to 
study the QD labeled cells. Overall the project has produced luminescent nanoprobes that 
enable the study of FAC formation dynamics and potentially a better in vivo fluorescent 
marker tool.  
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CHAPTER I 
INTRODUCTION AND MOTIVATION 
 
Semiconductor nanocrystals or Quantum Dots (QDs) have rapidly gained popularity 
as a fluorescent tool in biomedical/biology labs (The terms semiconductor nanocrystals 
and QDs are used interchangeably throughout the text). Favorable properties such as size 
tunable absorption/emission, improved photostability and narrow emission peak to 
enable spectral multiplexing contribute towards their popularity.
1-4
 In addition to ex vivo 
labeling, QDs have recently also been used for in vivo applications.
5, 6
 Significant 
progress has been made in fabricating monodisperse QDs,
7
 while a variety of coating 
chemistries have been developed to make these particles both water soluble and 
biocompatible.
8, 9
 Current techniques to solubilize the QDs rely on 
1. Ligand exchange using thiols
2, 10
 
2.  Ligand exchange using oligomeric phosphines,
11
 dendrons,
12
 and peptides
13
 
3. Encapsulation by a layer of amphiphilic diblock or triblock copolymers
5
 
4. Encapsulation by silica shells,
3
 phospholipid micelles,
1
 polymer beads,
14
 polymer 
shells,
15
 or amphiphilic polysaccharides
16
 
5. Combination of layers of different molecules giving the necessary colloidal 
stability to qdots
17
  
 
____________ 
This thesis follows the style of 
ano Letters. 
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Procedures to employ ligand exchange using any of the above mentioned primers are 
easy to implement, however, the bond holding the primer to the nanocrystal is dynamic, 
and thus yields relatively low stability to the system in water. Furthermore, during the 
ligand exchange process there might be slow dissolution of CdSe/ZnS in solution, which 
limits the applicability of this system for biological applications.
18
 
The procedures of encapsulating QDs with polymers have been quite involved.
19
 The 
resultant particles have been successfully used for ex vivo applications. However, their 
feasibility for use in in vivo applications has been limited by their half-lives in biological 
systems.
19, 20
 
While the use of recombinant proteins to coat the QDs after ligand exchange has 
been reported earlier,
17, 21
 no known literature exists on noncovalently coating the QDs 
with a natural protein without prior ligand exchange.
17, 21
 
This report discusses the fabrication, characterization and application of silk fibroin 
coated QDs. Silk fibroin is fibrillar protein derived from the Bombyx mori silkworm. 
Furthermore, the conjugation of the SF coated QD particles to different marker proteins 
using the conventional EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride) chemistry is reported. Additionally, the results of performing AFM-TIRF 
imaging of cells labeled with this particle/protein system are discussed.  
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CHAPTER II 
BACKGROUND 
 
Quantum Dots (QDs) result from the quantum confinement of electron hole pairs 
(excitons) in all three spatial dimensions.
22
 The first experimental evidence of the 
existence of such quasi-zero dimensional particles was reported by Ekimov and 
colleagues.
23
 Murray et al published the first report on colloidal synthesis process of 
fabrication of nearly monodisperse CdX (X-Se, Te, S) QDs.
24
 Many researchers have 
reported adaptations of this technique subsequently.
25-28
 Peng and Peng reported a 
modified route to the synthesis of CdX nanocrystals.
7
 Our lab utilized an adaptation of 
the Peng and Peng approach to synthesize II-VI CdSe semiconductor nanocrystals. The 
nanocrystals were fabricated using the high temperature organometallic synthesis 
procedure. Fabrication was carried out at 300
0
 C under nitrogen environment.  
For surface passivation and to enhance the quantum yield of these particles, an 
inorganic coating of ZnS shell was epitaxially grown on these dots.
29
 The outer surface 
of the core/shell assembly was covered by trioctylphosphine oxide (TOPO)* used as 
coordinating ligand during the fabrication reaction. These hydrophobic TOPO ligands 
made the QDs insoluble in solvents such as water, which in turn also rendered them bio-
incompatible.  
As discussed in the previous section, various techniques have been proposed to 
circumvent the issues of water solubility and biocompatibility of QDs. QDs coated with 
different synthetic polymers have gained popularity for in-vitro
30
 and ex vivo labeling
31
 
4 
 
 
 
but have been less successful for in vivo applications due to their half-lives in biological 
systems.
20, 32
 
To alleviate these issues, it was decided to coat QDs with a natural protein. The 
choice of a natural protein, silk fibroin (SF), was guided by the desirable properties of 
SF. Some of these properties such as oxygen and water permeability, relatively low 
thrombogenecity, low inflammatory response, protease susceptibility, and high tensile 
strength with flexibility directly influence the applicability of these particles for in vivo 
studies.
33-35
 The structure of SF consists of a light chain and a heavy chain linked by a 
single disulfide bond. The light chain is approximately 25 kDa and the heavy chain is 
approximately 325 kDa in mass.
36
 A sericin coating binds the two chains together. 
Removal of this sericin coating is necessary to lower the thrombogenecity and 
inflammatory response of SF.
35
  Use of SF to coat nanoparticles for drug delivery and 
the evaluation of it’s performance in vivo has been reported earlier.
33
 Since 
biocompatibility is necessarily a surface phenomenon, it was natural for us to speculate a 
similar biocompatibility profile for QDs coated with SF. 
Thus, there were two major scientific goals, that dictated the need for the 
development of such particles: 
1. Need for QDs with better applicability for in vivo studies. 
2. Need for a tool to label focal adhesion complex (FAC) proteins. 
2.1 FAC Background 
Cells produce extracellular matrix (ECM), organize it, and degrade it. Through 
matrix receptors, transmembrane proteins, this matrix is tied to the intracellular 
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components of the cells. It is believed that this matrix not only provides mechanical 
support to the cells but also plays a significant role in mechano-transduction of signals 
from the extra-cellular environment to the inside of the cell. This ECM signaling plays 
an important role in coordinating cell growth and development.
37
 Furthermore, it 
contributes towards cell behavior in response to perturbation in homeostasis.
38
 Recent 
developments also suggest the role of matrix receptors in cancer progression and 
potential therapeutic approaches exploiting this role.
39-41
 
Although several types of molecules are studied as matrix receptors, integrins are the 
most widely studied. Furthermore, one of the most intensely researched modes of 
integrin signaling comes through the study of focal adhesions.
42
 Focal adhesions are the 
anchorage points of the plasma membrane of a cell on the substratum over which it is 
moving.
43
 At the point of adhesion, integrins cluster and provide anchorage to the cell. 
When integrins cluster, focal adhesion kinase (FAK) is recruited by intracellular anchor 
proteins such as talin or paxillin. The clustered FAK molecules in turn cross 
phosphorylate and create docking sites for a variety of other intracellular signaling 
proteins such as vincullin, creating a link between the extracellular matrix and the 
cytoskeleton. Integrin mediated adhesions can undergo dynamic changes transforming 
from dot-like focal complexes to stress fiber associated focal contacts and maturing  to 
form fibronectin bound fibrillar adhesions.
44
 Intracellular anchorage to the adhesion is 
provided by actin fibers. Figure 1 shows a schematic of a focal adhesion complex. 
 
 
6 
 
 
 
 
Figure 1. Sketch showing the focal adhesion complex (FAC) formed at the  
cell-matrix interface
42
.  
 
Although the statics of the formation of integrin-mediated adhesions have been 
studied in detail earlier,
45
 recent development suggests that an important role is played 
by other proteoglycans, such as syndecans, in the adhesion formation dynamics and the 
signaling pathways associated.
46-48
 Of special interest is the role of adhesion dynamics in 
designing engineered tissue scaffolds
49
 and in designing better drug delivery vehicles.
50
 
The current scenario dictates development of an imaging tool that enables the study 
of cell adhesion dynamics. In response to these issues, this thesis describes the 
development of a luminescent nanoprobe that would enable the study of cell adhesion 
dynamics. Also presented are images demonstrating the labeling of endothelial cells with 
these nanoprobes. Fluorescence imaging of cells labeled with these particles was 
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performed along with TIRF and AFM imaging. The following sections will explain in 
detail the advantages of using these imaging tools over traditional epi-fluorescence 
imaging. 
 
2.2 Total Internal Reflection Fluorescence Microscopy (TIRF) 
Different mechanisms are often employed in fluorescence microscopy to restrict the 
area of a specimen excited by a light source. This type of restriction often results in an 
improved signal-to-noise ratio, which translates into a better spatial resolution. Total 
Internal Reflection Fluorescence microscopy (TIRF) utilizes evanescent waves to 
illuminate a limited specimen region (approx 100 nm) immediately adjacent to the 
interface between two media having different refractive indices.  
 
2.3 Principle of Evanescent Wave Generation 
The schematic in figure 2 shows the principle of “evanescent waves” that governs 
TIRF systems: 
 
Figure 2. Schematic illustrating the principle of generation of “evanescent waves” at the 
interface of materials with different refractive indices. 
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Snell’s law gives the relationship between angles of incidence and refraction for light 
impinging on the interface of two media with different refractive indices. The following 
equation describes the Snell’s law: 
n1 sinθ 1 = n2 sinθ 2   
where n1 and n2 are refractive indices of the two media, and θ1 and θ2 are angles of 
incidence and refraction respectively. 
When light traveling through a medium of high refractive index is incident on an 
interface with a low refractive index material on the other side, at an incidence angle θc, 
such that the refracted light makes an angle of 90
0
 with the normal, this angle is known 
as the critical angle and is given by, 
θ c = sin 
–1
(n2/n1) 
If the light is incident at an angle greater than the critical angle the light gets “Totally 
Internally Reflected” (TIR) and no refracted wave is produced. Furthermore, at the 
interface a standing wave or an “evanescent field” propagates through the low refractive 
index material. The frequency of the evanescent field is the same as that of the incident 
light and the intensity of the evanescent field exponentially “decays” with distance.  
The intensity of the evanescent field decreases exponentially with distance and is 
given by: 
 
                  where, 
    
[ ] 2
1
2
2
22
1
0
0
sin
4
)(
−
−
−=
=
nnd
eIzI d
z
θ
π
λ
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where, I(z) is the intensity of the evanescent wave at a height, z, above the interface, I0 is 
the initial intensity, λ0 is the wavelength of the incident light, and d is the distance 
travelled by the evanescent field from the interface. 
TIRF has been used to visualize cell-substrate interface.
51-53
 Furthermore, since the 
evanescent field illuminates a small distance into the cell, avoiding the unwanted 
fluorescence acquired from the rest of the cell, studies have shown a substantial 
improvement in the  signal-to-noise ratio while imaging cell-substrate contacts using 
TIRF imaging over epi fluorescence imaging.
54
  TIRF has also been used to study 
individual components of the FAC such as the actin filaments.
55
 Other applications of 
TIRF studied so far include: 
1. visualization and spectroscopy of single molecule fluorescence near a surface
54, 
56-60
 
2. tracking of secretory granules in intact cells before and during the secretory 
process
61, 62
 
3. measurements of the kinetic rates of binding of extracellular and intracellular 
proteins to cell surface receptors and artificial membranes
53, 63
 
4. micromorphological structures and dynamics on living cells
64, 65
 
5. long term fluorescence movies of cells during development in culture
66
 
6. comparison of membrane-proximal ionic transients with simultaneous transients 
deeper in the cytoplasm
67
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Hence, if we combine the advantages of TIRF system, high signal-to-noise ratio and 
an ability to excite the FAC (region of interest for the author), with the advantages of 
QDs, such as ability to spectrally multiplex the information, it would provide a very 
effective tool to study the dynamics of formation and functioning of a Focal Adhesion 
Complex (FAC). 
 
2.4 Atomic Force Microscopy 
Atomic Force Microscopy (AFM) is a member of the family of Scanning Probe 
Microcopies (SPM). It measures inter-atomic forces between the AFM cantilever and the 
surface while spatially scanning the surface.
68
 In its simplest form an AFM works by 
scanning, raster scan, the surface of interest with a tiny tip mounted at the end of a 
cantilever. A piezoelectric actuator enables sub-angstrom accuracies in the tip-surface 
separation. The deflection of the cantilever, resulting from its interaction with the 
surface being scanned, is monitored using a precision laser. The laser beam is reflected 
from the back surface of the cantilever tip towards a split photodetector, that amplifies 
the cantilever deflections. A negative feedback loop, connected to the cantilever 
deflection sensor, keeps the tip surface interaction at a fixed value controlling the tip 
surface distance. The amount of feedback signal received at each scanning point is used 
to reconstruct the topography of the surface being scanned.
69   
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Figure 3. Schematic of an AFM coupled with an inverted microscope
69
.  
 
 
 
A schematic of the AFM system used for this research is shown in figure 3.  Use of 
AFM for biological imaging and for manipulation of biological macromolecules have 
been reported earlier. Some of the biological applications have included: 
1. Studying the dynamics of cell division for adherent cells
70
 
2. Antibody recognition imaging
71
 
3. Drug discovery by studying the effect of specific molecules on the cytoskeleton 
of the cell
72, 73
 
4. Unzipping DNA molecules
74
 and bacterial surface layers
75
 
5. Study of protein mechanics
76
 
6. Study the statics of focal adhesion complex (FAC) formation
77
 
Recent studies have used combined AFM-TIRF approach to study cellular 
mechanics.
65, 78
 A similar approach is reported in this thesis, describing the use of AFM-
TIRF microscopy to image QD labeled FAC proteins. An AFM tip can be used in 
tapping mode to induce formation of FAC and the TIRF system can simultaneously be 
used to image the dynamics of this formation. Previous studies reporting the use of QDs 
12 
 
 
 
as fluorophores to carry out combined AFM-TIRF imaging have relied on labeling the 
AFM tip with QDs.
79
 As reported in the study, the approach results in a very sensitive 
nano-ruler based on fluorescence and can be used to study processes such as protein 
unfolding. The technique described in this thesis modifies this approach to label the FAC 
proteins and study the formation of FAC, induced by AFM tip, using TIRF signal.  
13 
 
 
 
CHAPTER III 
MATERIALS AND METHODS 
 
3.1 Fabrication of QDs 
 High quality monodisperse CdSe/ZnS QDs were prepared using an adaptation of a 
method previously described in literature.
7
 The target amounts of all chemicals used are 
given in table I. cadmium oxide (CdO, Alfa Aesar – 99.998%), tetradecyl phosphonic 
acid (TDPA, Alfa Aesar – 98%) and trioctyl phosphine oxide (TOPO, Sigma Aldrich – 
99%) were taken in a 3-neck flask and were heated to 340
0
 C for 1 hour under constant 
Ar flow (approx 1ml/s). The heating was carried out in a metal bath containing an alloy 
of bismuth with a melting point of 110
0
 C. The temperature of the metal bath was 
measured using a type-K thermocouple in a stainless steel sheath, providing feedback to 
a (Omega CSC32) benchtop controller. This step was used to reduce CdO to Cd
2+
. The 
presence of TDPA allowed the binding of Cd
2+
 to the coordinating solvent, TOPO in our 
case.  
A shot of TOP:Se (trioctyl phosphine, Sigma Aldrich 90% : selenium powder, 
Sigma Aldrich 99.99%)  was prepared because it is easier, safer and more convenient to 
handle as compared to Se powder. The molar concentration of Se used to prepare this 
shot was 30% more than that of Cd
2+
. This exhausts all the Cd
2+
 during the fabrication 
process reducing the chances of background noise signal from Cd photoluminescence. 
The Se shot was prepared in a round bottom flask with a resealing cap that permitted Ar 
purging of the flask. The purging prevents oxidation of the TOP. The solution was 
14 
 
 
 
stirred using a teflon coated magnetic stirrer for 1 hour, allowing the selenium to 
dissolve in the TOP.  
 
Table 1. Amounts of each chemical used in the fabrication of one standard batch of 
CdSe quantum dots. 
Chemical: TOP Se CdO TDPA TOPO 
Amount: 2.4 ml 0.0411 g 0.0514 g 0.0566 g 3.7768 g 
 
 
 
Table 2. Amounts of each chemical used in growing a ZnS shell over a standard batch of 
CdSe quantum dots. 
Chemical: TOP Dimethyl Zinc Hexamethyldisilathiane 
Amount: 6.3 ml 1.6 ml 0.42 ml 
 
 
The temperature of the Cd
2+
 containing flask was lowered to 300
0
 C. The TOP:Se 
precursor (generally 2.6 ml) was aspirated out from the round bottom flask using a 12 
inch, 18-gauge stainless steel needle and was injected very slowly in the Cd containing 
flask.  
The reaction was allowed to continue for 7 min. The reaction time governs the size 
of the particles and by implication the photoluminescence emission peak wavelength of 
the particles. At this point, the CdSe QD cores are ready. But to improve the 
photoluminescence quantum yield of the nanocrystals and to achieve surface passivation 
of the QD surface, the QD cores are overcoated with ZnS to form a core/shell QD. 
A ZnS precursor was prepared using dimethyl zinc (DMZ, Sigma Aldrich – 1 M in 
Heptane), and hexamethyldisilathian (HMDS, Sigma Aldrich) and using TOP as a 
15 
 
 
 
solvent. Again, like TOP:Se the ZnS precursor was prepared in a round bottom flask 
with a resealing cap to allow purging of the flask with Ar. The ZnS precursor was 
allowed to react for 2 hours before using it to coat CdSe QDs. 
Immediately following the CdSe core synthesis, the temperature of the reaction pot 
(CdSe QDs) was reduced to 200 C. ZnS precursor was injected into this pot very slowly 
(approx. 3ml/min) using a 12 inch, 18-gauge needle. To ensure the growth of a thin layer 
of ZnS, the ZnS was allowed to grow for 30 min. Afterwards, the temperature of the 
flask was reduced to 100
0
 C. This allowed the annealing of the core/shell QDs.  
Samples of QDs were then quenched in Methanol (EMD). A glass eye dropper was 
used to aliquot the samples out of the reaction pot (0.8+/-0.2 ml) in 10+/-2 ml methanol. 
The high QD to methanol ratio would ensure immediate quenching of the reaction. 
These samples were cleaned repeatedly with methanol to remove excess unreacted 
TOPO. To carry out the cleaning process the samples were repeatedly centrifuged out of 
methanol and re-suspended again in methanol. After 4 cleaning cycles, the sample were 
re-dispersed in chloroform (Sigma Aldrich) for storage. A photograph of the 
experimental setup used to carry out the entire synthesis process is shown in figure 4. 
16 
 
 
 
 
Figure 4. Experimental set up to fabricate quantum dots. 
 
3.2 Water Solubility of QDs 
Figure 5 is the schematic of an average CdSe/ZnS/TOPO QD made in the lab: 
 
 
Figure 5. Schematic of CdSe/ZnS/TOPO QD. 
 
To make these particles water soluble, an additional coating is required. Initially, we 
coated them with polyethyleneimine (PEI). Figure 6 shows the chemical structure of PEI 
and figure 7 is a schematic showing the coating of TOPO coated QDs with PEI. 
17 
 
 
 
 
 
Figure 6. Structure of polyethyleneimine (PEI). 
 
 
Figure 7. Schematic showing the coating of CdSe/ZnS QDs by PEI. 
 
3.3 PEI Coating of QDs 
Earlier reported technique
8
 to coat QDs with PEI was modified for use in our lab. 10 
ml of cleaned CdSe/ZnS/TOPO was alliquoted in a scintiallation vial using a micro-
pipette (OD=0.1). 1 mg of PEI (polyethyleneimine, Sigma Aldrich 408727) was added to 
the vial. The mixture was vortexed and allowed to react for 10 min. The solvent from the 
vial was then vacuum dried. The thin coating left on the inner wall of the vial at the end 
of the drying process was re-dispersed in DI water. The PEI coating was achieved and 
the QDs became soluble in water.  
There were 2 original goals that the coating process was designed to achieve: 
18 
 
 
 
1. Make the QDs water soluble  
2. Make them biocompatible 
Examination of the sample demonstrates that the PEI coated QDs were water 
soluble. 
 
3.4 Cell Cultures 
To test the biocompatibility of PEI coated QDs, HeyA8 ovarian cancer cells were 
cultured using RPMI 1640 media with 10% FBS and 1% gentamycin. The cells were 
cultured in T75 flasks. The concentration of the cultured cells was 1x10
6
 per flask. The 
cell vial was taken out of liquid nitrogen and incubated to 37
0
 C in a water bath. 1 ml of 
cells were transferred from the vial to a 10 ml conical flask containing 9 ml media. The 
cells were then centrifuged out of the media. The conical flask was placed in a centrifuge 
at 4
0
 C and centrifuged at 200 g. After centrifugation thee supernatant was aspirated out 
of the flask and the cells were resuspended in 10 ml media. The media containing the 
cells was then transferred to T75 flasks and the flask was placed in the incubator. The 
entire process was carried out aseptically inside a biological safety cabinet. The media 
was changed every 2 days. When the cultured cells reached confluence, they were 
exposed to PEI coated QDs. 3 ml of QD/PEI (OD=0.1 cm
-1
) was used per flask. The 
cells were exposed to the QDs for 1 hour. At the end of 1 hour, the QDs were aspirated 
out of the flask and the flask was given 3 PBS washes. 10 ml of media was then added to 
the flask.  
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3.5 Silk Fibroin Coating of QDs 
The silk fibroin coating of QDs was carried out in three steps. 
3.5.1 Degumming Silk 
Raw silk for this project was kindly donated by Dr. S. Hudson (TECS, North 
Carolina State University, Raleigh, NC). As mentioned in the introduction section, the 
raw silk has a sericin coating, which must be removed to reduce the thrombogenecity of 
the silk. The removal of sericin coating is known as the “degumming process”. 0.25% 
w/v sodium dodecylsulfate (Sigma Aldrich) and 0.25% w/v sodium carbonate (Sigma 
Aldrich) were dissolved in ultra-pure water. This soap solution was then placed in a 
glass beaker on a magnetic stirrer and brought to 100
0
 C. Raw silk was added at 1:100 
w/v. The mixture was heated for 1 hour. The alkaline soap solution was then drained and 
the degummed silk was heated to 100
0
 C in distilled water for an additional hour to wash 
the surfactant from the silk. Finally, remaining sericin and surfactants were removed 
completely by rinsing the silk under running distilled water. The washed silk was then 
air dried and stored.
80
 
3.5.2 Coating of QDs with Degummed Silk 
 0.1% w/v solution of degummed silk fibroin was prepared in chloroform and the 
solution was then sonicated. Samples were prepared with 1, 2, 3 and 4 hours sonicated 
silk fibroin in chloroform. It is speculated that the beta sheet structure of silk fibroin gets 
broken into a random coil structure during the sonication process. Sonicated silk fibroin 
(SF) solution was then added to QDs (absorbance = 0.1 cm
-1
) in chloroform. 50% v/v 
solution was prepared. This solution was further sonicated for 5 min to achieve 
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homogeneity. The coating of QDs by SF was almost instantaneous. A schematic of the 
coating process is shown in figure 8.  
 
 
Figure 8. Schematic showing the encapsulation of CdSe/ZnS QDs by SF. 
 
3.5.3 Crystallization of SF Coated QDs 
The solvent from the SF coated QDs was vacuum dried. A thin layer of SF coated 
QDs was left on the walls of the vial. 50% v/v methanol (MeOH) and DI water was 
added to the vial. The amount of this solution was just enough to cover the QD layer 
(approx 1 ml). The solution was gently mixed. The solvent from the resultant solution 
was heated off at 70
0
 C. A layer of crystallized SF coated QDs was left behind on the 
inner walls of the vial. This was re-dispersed in 10 ml DI water. The solution was 
sonicated for 10 min to achieve homogeneity and re-dispersion of QDs in water.  
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3.6 Characterization of SF Coated QDs 
3.6.1 Optical Characterization of SF Coated QDs 
 The photoluminescence (PL) spectra of uncoated QDs and SF coated QDs were 
recorded using quantamaster fluorometer (Photon Technologies International – PTI); a 
fluoremeter, designed to detect the fluorescence or photoluminescence from a sample, is 
equipped with a wide spectrum light source that is filtered through a monochromator that 
adjusts the wavelength of the excitation light allowed to pass through to the sample to 
excite it. The setup of the equipment is given as a part of the appendix. For standard PL 
characterization, an excitation wavelength of 465 nm was used with a 5 nm excitation 
slit and an integration time of 1s, while the emission was monitored from 500 to 700 nm 
with a 1 nm emission slit.  
3.6.2 Photoluminescence Quantum Yield 
Photoluminescence Quanutm Yield (PLQY) measurements were carried out by 
comparing the ratio of integrated PL counts of QDs/SF to that of rhodamine 6G 
(reference). The PLQY of R6G is known to be 95.5% ± 2%. The excitation wavelength 
used was 500 nm, the peak emission wavelength was 555 ± 10 nm, absorbance at the 
excitation wavelength 0.05 ± 0.02 cm
-1
 and the length of the sample 1 cm (std glass 
cuvette – 1 cm wide).  
3.6 3 Size Distribution 
Transmission electron microscopy (TEM) was performed using a JEOL JEM – 
1010 microscope.  The crystallized SF coated QDs appeared monodisperse with a size 
range of 10-14 nm. To corroborate this result, Atomic Force Microscopy (AFM) was 
performed on these particles using Veeco scientific’s Bioscope II.  
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3.6.4 Cell Cultures 
To test the biocompatibility of SF coated QDs the same procedure as was used with 
PEI coated QDs was followed. HeyA8 ovarian cancer cells were cultured using RPMI 
1640 media with 10% FBS and 1% gentamycin. When the cultured cells reached 
confluence, they were exposed to SF coated QDs. 3 ml of QD/SF (concentration=0.1 cm
-
1
) was used per flask. The cells were exposed to the QDs for 1 hour. At the end of 1 
hour, the QDs were aspirated out of the flask and the flask was given 3 PBS washes. 10 
ml of media was then added to the flask.  
3.6.5 Protein Conjugation 
To label the different cell components with a high degree of specificity, there was a 
need to conjugate QDs/SF with labeling proteins. Samples of SF coated QDs conjugated 
to streptavidin and phalloidin were prepared.
81
 
 
3.7 QD/Streptavidin Conjugation 
Modified EDC chemistry was used to prepare QD streptavidin conjugates. The 
procedure was modified from that given along with the product kit by Pierce (See 
appendix). 1 mg EDC (approx 2mM) was mixed with 1.1 mg of sulfo-NHS (approx 5 
mM) in a glass vial. The mixture was vortexed to ensure homogeneity. 1 ml of 
streptavidin was added to the mixture and the reaction allowed to progress for 15 min at 
room temperature. 1.4 microliter of 2-mercaptoethanol was added to quench this 
reaction. The mixture was vortexed again to ensure homogeneous quenching of the 
reaction. SF coated QDs were added to this vial. The QDs were allowed to react with the 
activated streptavidin for 2 hours. After 2 hours, the reaction was quenched by adding 
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10mM Hydroxylamine. The mixture was then centrifuged using centrifuge filter tubes to 
remove any unused reactants from the mixture. The supernatant was collected in a 
separate vial.  
 
3.8 QD/Phalloidin Conjugation 
Modified EDC chemistry was used to prepare QD phalloidin conjugates. 1 mg EDC 
(approx 2mM) was mixed with 1.1 mg of sulfo-NHS (approx 5 mM) in a glass vial. The 
mixture was vortexed to ensure homogeneity. 1 ml of phalloidin was added to the 
mixture and the reaction allowed to progress for 15 min at room temperature. 1.4 
microliter of 2-Mercaptoethanol was added to quench this reaction. The mixture was 
vortexed again to ensure homogeneous quenching of the reaction. SF coated QDs were 
added to this vial. The QDs were allowed to react with the activated phalloidin for 2 
hours. After 2 hours, the reaction was quenched by adding 10 mM Hydroxylamine. The 
mixture was then centrifuged using centrifuge filter tubes to remove any unused 
reactants from the mixture. The supernatant was collected in a separate vial. 
 
3.9  Labeling of Cell Surface Proteins Using QD/Streptavidin Conjugates 
In order to label the cell surface proteins with QD/streptavidin conjugates, the cell 
surface proteins were biotinylated using a standard biotinylation kit (Pierce Biotech, 
89881). The following was the procedure followed to biotinylate HeyA8 Cells:
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1. Media was aspirated from the flask containing the cells. 
2. The cells were given 3 PBS washes using ice-cold PBS (pH = 8) to remove all 
the amine containing media and proteins from the cells. 
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3. The cells were then trypsinized, 5 ml of trypsin per flask, and allowed to detach 
from the flask surface for 5 min. 
4. The trypsin was neutralized using PBS and the cells were suspended in PBS at a 
concentration of 25x10
6
.  
5. 1 mg of sulfo-NHS-Biotin per ml of cells was added. The approximate 
concentration of the resulting biotin reagent was 2 mM. 
6. The reaction was then allowed to continue at room temperature for 30 min. 
7. The cells were then transferred to a glass cover slip. 
8. After 1 hour, the cells were given 3 PBS + 10 mM glycine washes to quench and 
remove excess biotin reagent and byproducts. 
9. The flask was then exposed to 3 ml of QD/streptavidin (OD = 0.1). 
10. After 1 hour of exposure, the cells were washed with PBS (3x) and media was 
added to them. 
 
3.10  Labeling of F-actin Using QD/phalloidin Conjugates 
In order to label F-actin inside the Human Umbilical Vein Endothelial Cells 
(HUVECS), the cells were fixed, permeabilized and then exposed to QD/phalloidin. The 
following steps describe the method used to achieve this: 
1. The media was removed from the slide on which HUVECS were grown earlier. 
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2. 1 ml of 3.7% formaldehyde was added to the slide. Formaldehyde had been pre-
heated to 37
0
 C. 
3. The cells were incubated with 3.7% formaldehyde at room temperature for 10 
min. 
4. Formaldehyde was then aspirated out and 3 PBS washes were given to the cells. 
5. 1 ml of 90% methanol was added per slide. Methanol had been pre-cooled to -20
0
 
C. 
6. The cells were then incubated at room temperature for 5 min. 
7. After the methanol was aspirated, the cells were again given 3 PBS washes. 
8. The cells were then exposed to 1 ml of QD/phalloidin (OD = 0.1) per slide and 
incubated at room temperature for 1 hour. 
9. After 1 hour the QDs were aspirated out and the PBS added. The cells were now 
ready for imaging. 
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CHAPTER IV 
RESULTS 
 
 This section will report the results achieved during the project. As mentioned in the 
materials and methods section, CdSe quantum dots were fabricated and were coated with 
ZnS to improve the quantum yield of the particles. Figure 9 demonstrates this 
phenomenon.  
 
 
 
Figure 9. Emission curve for CdSe vs CdSe/ZnS QDs in chloroform.  
 
The luminescence intensity is plotted for absorbance matched samples and the 
improvement in intensity is better than an order of magnitude (14.4358 times). This 
value is comparable to the values reported in the literature
83
. Samples with emission 
peaks ranging from 545 – 610 nm were prepared for various studies. The FWHM of 
samples varied from approximately 30-40 nm. The higher FWHM curves corresponded 
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to longer reaction times and implicitly longer emission peak wavelength. “Ostwald 
ripening”
24
 is responsible for the widening of the FWHM. Once the reactants are used up 
in the reaction pot, the higher energy of smaller nanocrystals promotes their dissolution 
and this dissolved material gets deposited on larger nanocrystals. This results in a greater 
inhomogeneity in the size distribution of the sample and consequently a broadening of 
the emission spectra. This broadening of the emission spectra is also known as 
“inhomogeneous broadening”.  
To make the QDs water soluble, the QDs were coated with PEI. Figure 10 shows the 
emission curve for a representative sample of PEI coated CdSe/ZnS QDs. The quantum 
yield of QDs was decreased to 90% of original as a result of PEI coating. The pH of PEI 
coated QDs was acidic (approx 5.5). The pH of the solution was neutralized by adding 
appropriate amount of NaOH.  
 
 
 
 
 
Figure 10. Emission curves for absorption matched CdSe/ZnS QDs in chloroform and 
PEI coated CdSe/ZnS QDs in water.  
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  HeyA8 cells were cultured and exposed to the PEI coated QDs as described in the 
materials and methods section. The sample was excited using a 488 nm light source. The 
QDs emitted at 580 nm. The cells were imaged 1 hour post exposure. Zeiss Axio 
Observer microscope was used to image the cells. As shown in figure 11 below almost 
all the cells died within 1 hour post exposure.  
 
 
 
 
Figure 11. Fluorescence image of HeyA8 cells exposed to PEI coated CdSe/ZnS QDs. 
Image taken at t=1 hr post exposure.  
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 We speculate that since the PEI is positively charged, the aggregation of these 
particles inside the slightly negatively charged plasma membrane lead to this toxic 
effect. As a result of this negative result on preliminary cytotoxicity study, we decided 
against using PEI for subsequent work. To alleviate the shortcomings of the known 
coating procedure, a new coating material was needed.    
 SF was chosen as a coating material due to the many desirable properties
33-35
 it has 
(see Introduction). QDs were then coated with silk fibroin (SF) as described in the 
experimental section. To characterize these particles TEM and AFM were carried out. 
Figures 12 and 13 show results of TEM imaging. Figure 12 is a representative of the 
uncoated QDs. The size of the uncoated CdSe/ZnS QDs in chloroform was found to be 
4.378 ± 1.11 nm. Since the uncoated CdSe/ZnS quantum dot was suspended in 
chloroform, which would dissolve the formvar coating of the copper grid used in the 
TEM, the solution was diluted using ethanol. Three different dilution factors were used; 
1:2, 1:1, and 2:1 ratios of QD/chloroform to ethanol. QDs appeared aggregated in 1:2   
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Figure 12. TEM of uncoated CdSe/ZnS QDs in chloroform. Size distribution for these 
particles was 4.378 ± 1.11 nm. The image corresponds to a 2:1 dilution of 
QD/chloroform in Ethanol. 
 
  
and 1:1 dilutions but appeared well distributed in the 2:1 dilution. 20 images per sample 
were collected with magnifications of 50K, 100K, 200K and 250K. (Dr. Ken Dunner at 
MDACC and Dr. Zhiping Luo at TAMU helped us get the images.) 
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   Figure 13 shows crystallized silk fibroin coated quantum dots. The size distribution of 
this sample was found to be 17.59 ± 20.35 nm. The large standard deviation is indicative 
of polydispersity. Closer examination of the image indicates presence of larger size silk 
particles that did not coat QDs. To improve the size distribution of SF coated QDs the 
silk particles needed to be precipitated out of the sample. Size selective precipitation was 
used to achieve this. Crystallized SF coated sample was transferred to centrifuge tubes (1 
ml per tube) using a micro-pipette and was centrifuged at 5000 g for 6 min. Since the 
non-coating silk fibroin particles were larger in size as compared to the SF coated QDs, 
they settled at the bottom of the centrifuge tubes. The supernatant was then collected in a 
separate vial using a micro-pipette.   
 In figure 14 the size distribution of centrifuged SF coated QDs was 6.65 ± 2.99 nm. 
The particles were fairly monodisperse as denoted by the standard deviation. A visual 
inspection of the TEM image confirms this.  
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Figure 13. TEM image of crystallized SF coated QDs. Size distribution of these particles 
was 17.59 ± 20.35 nm. The particles were unprecipitated at this point. 
 
 
 
Non-coating SF 
particles 
Crystallized SF coated 
CdSe/ZnS QDs 
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Figure 14. TEM image of crystallized and centrifuged SF coated CdSe/ZnS QDs. Size 
distribution for this sample was 6.65 ± 2.99 nm. 
 
   To corroborate this data AFM was carried out on these samples. Approximately 1 ml 
of QD sample was transferred from the vial to a microscope cover slip using a micro 
pipette. A smear of these dots was prepared by sliding a cover slip over the drop of 
sample. Figures 15 and 16 show AFM results of uncoated and SF coated QDs. The AFM 
was used in tapping mode air. The coated quantum dots seem to have a preferential axis, 
34 
 
 
 
which is aligned with the direction of AFM tip scan. This is indicative of soft coating of 
the particles. It would be safe to speculate that this would act as an added degree of 
freedom when the particles are used for in vivo studies as the soft coating will allow for 
the particles to face lesser steric hindrance while traversing through blood capillaries. 
 
 
 
Figure 15. AFM image of uncoated CdSe/ZnS QDs. A smear of the QDs was prepared 
on a cover slip and scanned using Veeco Scientific’s Bioscope II in tapping mode air. 
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Figure 16. AFM image of crystallized SF coated QDs. 
 
   An initial study of the optical properties of SF coated QDs indicated a blue shift in the 
peak emission wavelength of QDs as shown in figure 17. The amount of shift was a 
function of the number of hours of SF sonication. Figure 18 shows the blue shift for a 4 
hour sonicated sample. The peak emission wavelength shifted by approximately 90 nm 
to the blue end of the spectrum. Owing to the approximately 2 nm size micro-fibrils
84
, 
resulting from 4 hours of sonication time, consisting of polypeptide chains of gly-ala-
gly-ala-gly-ser-gly-ala-ala-gly-tyr
84
, we speculated a change in the energy landscape that 
the exciton experienced.   
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Figure 17. Blue shift of peak emission wavelength of QDs believed to be resulting from 
SF coating. 
 
   A detailed analysis of the particles, however, revealed formation of aggregates of these 
particles. A representative TEM image is given in Figure 18 demonstrating this 
observation. To rectify this situation a procedure was developed to crystallize these 
samples as was described in the experimental section. Post crystallization, size selective 
precipitation was carried out. Figure 19 is the emission curve of the crystallized SF 
coated QDs. The curve corresponds to a sample prepared by 4 hours of sonication. 
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Figure 18. TEM image of aggregated uncrystallized SF coated QDs. 
 
 
 
 
 
 
Figure 19. Normalized emission curve for crystallized SF coated QDs. 
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   The curve demonstrates a slight red-shift for coated QDs. This result is consistent with 
earlier reports of red shift in QD emission as a result of coating by amphiphilic block 
copolymer
5
 as SF is similar to an amphiphilic block copolymer.
85
 
 To verify the biocompatibility of SF coated QDs, HeyA8 cells were exposed to these 
particles. The cells were imaged using Zeiss Axiovert microscope at t=1 hr and t=12 
hours post exposure respectively. Figures 20 (a) and (b) are representative of t=1 hr 
images of these cells. The QDs appear to have enodcytosed with apparent mitigation of 
the cyto-toxicity of uncoated dots. The lack of floating cells and floating luminescent 
particles demonstrate that the SF coated QDs had either entered the cells or had been 
washed away during the PBS washes.  
 
 
      
Figure 20. T=1 hour post exposure fluorescence images of HeyA8 cells exposed to SF  
coated QDs. 
 
   Figures 21 (a) and (b) correspond to t=12 hours post-exposure images taken from the 
same set of cells. Although the SF coated QDs display no apparent cytotoxicity, the cell 
membranes fluoresce more than the rest of the cell body indicative of colocalization of 
the dots in the plasma membrane. Steric hindrance was believed to be the cause of this 
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and an investigation of the TEM pictures, figure 22, for the sample used for this study 
confirmed this. The peak emission wavelength of these uncoated particles was 580 nm, 
corresponding to the size that the core was expected to be. However, since the overall 
size of the uncoated particle was approx 100 nm with appreciable polydispersity in the 
sample, it was concluded that we had a far thicker ZnS shell than necessary.  The 
method of fabrication was modified to accommodate the necessary changes to decrease 
the size of the ZnS shell, the ZnS coating time was reduced from 60 minutes to 30 
minutes resulting in a couple of monolayers of ZnS coating. The fluorescent image 
shows a more even distribution of SF coated QDs across the cell body once the ZnS 
shell was reduced to a thin layer. 
   As shown in figure 23, with a decreased thickness of ZnS shell, the SF coated QDs 
were more evenly distributed across the shell with relatively lesser colocalization in the 
plasma membrane of the cell. The concentration of cells used on each flask was 1x10
6
 
cells. This is indicative of decreased steric hindrance, which can be attributed to a 
decreased overall particle size.  
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Figure 21. T=12 hour post exposure fluorescence image of HeyA8 cells exposed to SF 
coated QDs. 
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Figure 22. TEM images of uncoated and SF coated CdSe/ZnS QDs with a large (approx 
50 nm) ZnS shell on the CdSe core. 
 
 
 
 
 
 
Figure 23. T=12 hour post exposure. HeyA8 cells exposed to SF coated CdSe/ZnS QDs. 
 
42 
 
 
 
   To quantify the biocompatibility of SF coated QDs (610 nm peak emission 
wavelength) an MTT assay was carried out on HeyA8 ovarian cancer cells exposed to 
the SF coated QDs. The cell flask was trypsinized by adding 5 ml of trypsin to the flask. 
At 5 minutes, 5 ml of media was added to neutralize the trypsin and the cells were then 
collected in a 15 ml conical flask. The cells were the plated in the microtitter plate to a 
final concentration of 1x10
6
 cells/ml.  After 24 hours of incubation at 37
0
 C, media was 
removed from the wells. 100 ml of 10%  MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a tetrazole) stock solution prepared in RPMI media was 
added per well. The plate was then incubated for 4 hours. 100 ml isopropanol was added 
to each well. The well contents were mixed using multiple pipetting cycles. The plate 
was placed on a “Flow” plate shaker for 20 min at low speed. At the end of 20 minutes, 
the plate was read using ELISA reader at 570 nm. The results of the assay are 
summarized in figure 24. 
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Figure 24. MTT assay of HeyA8 cells exposed to SF coated QDs.  
 
   The principle of MTT assay is the reduction of MTT to purple Formazan. This 
reduction occurs only in the presence of mitochondrial enzyme. Therefore, the amount 
of MTT reduction (Formazan formation) is dependent on the percentage of live cells in 
the well. This was quantified using the ELISA spectrophotometer. Cells not exposed to 
SF coated QDs were used as control. No significant difference (P = 1.69 x 10
-7
) was 
found between control and test cells. Furthermore, incremental amounts of SF was used 
during the coating process to get incremental coating thicknesses. However, the 
absorbance values for groups exposed to QDs with different thickness coatings also did 
not show significant difference. This was attributed to the fact that at 570 nm QDs would 
also absorb the incident light and hence would induce an error term in the absorbance 
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values. Therefore, we concluded that MTT was not an ideal candidate to perform a 
live/dead study on these cells.   
   As described, a two step conjugation process was carried out to conjugate SF coated 
QDs to streptavidin and phalloidin respectively. Schematics shwoing the resultant 
particles and their subsequent use for cellular labeling are shown in figures 25 and 26. 
As shown in figure 25 streptavidin was conjugated on the surface of SF coated QD, 
using conventional EDC chemistry. The same technique was used to conjugate 
phalloidin to SF coated QDs as shown in figure 26. Proteins on the surface of HeyA8 
cells were non-specifically biotinylated using the piercenet biotinylation kit as described 
earlier. Biotinylated HeyA8 cells were incubated with streptavidin conjugated SF coated 
QD for 1 hour. Streptavidin has a very high affinity for Biotin and this results in high 
efficiency of coupling between the bio-conjugated dots and the surface proteins on 
HeyA8 cells.
86
 After 1 hour of incubation the QD solution was aspirated; the cells were 
given PBS washes (3X) and were imaged using the Zeiss microscope. Figure 27 shows a 
representative cell with the cell surface proteins labeled by SF coated QDs. As can be 
seen the entire surface of the cell has been labeled indicating a high efficiency of 
streptavidin-biotin coupling.  
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Figure 25. Schematic showing the 2 steps of labeling surface proteins on HeyA8 cells 
with streptavidin conjuagated SF coated QDs. 
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Figure 26. Schematic showing the 2 steps of labeling F-actin in HUVECS with 
phalloidin conjugated SF coated QDs. 
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Figure 27. Figure representing surface protein labeling of HeyA8 cells by streptavidin 
conjugated SF coated QDs. 
 
   Figure 28 shows the labeling of F-actin on the cyto-skeleton of human umbilical vein 
endothelial cells (HUVECS). The cells were fixed and permeabilized as described in the 
methods section. The cells were then incubated with phalloidin conjugated SF coated 
QDs for 1 hour at room temperature. Like streptavidin/biotin, phalloidin has a very high 
affinity towards F actin
87
. Hence, phalloidin conjugated SF coated QDs label F actin on 
the fixed HUVECS with high efficiency. Figure 27 demonstrates labeling of F actin 
fibers. The contrast is indicative of high efficiency of coupling between phalloidin 
conjugated SF coated QDs and actin fibers.  
48 
 
 
 
 
Figure 28. Labeling of F-actin in HUVECS using phalloidin conjugated SF coated QDs.  
The image has been false colored to enhance the contrast. 
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CHAPTER V 
DISCUSSION, CONCLUSION AND FUTURE WORK 
 
The experiments represent the first reported attempt to directly coat QDs with a 
naturally occurring protein. The technique reported here is significantly different from 
previously reported techniques.
2, 3, 88
 The self assembled coating system described here 
can be used to coat different core-shell structures. Some of the potential applications for 
these types of quantum dot/protein conjugate systems include cell surface labeling and 
intra-cellular tracking, tumor labeling, and for a variety of other imaging applications. 
The fabrication of CdSe/ZnS QDs was carried out using a one pot reaction method
7
. 
However, CdSe growth temperatures used were between 270
0
 C and 300
0
 C, whereas the 
temperature of ZnS growth was 200
0
 C. The cooling time for the metallic bath was 
highly dependent on the ambient temperature and hence was a potential source of error 
in the prediction of QD peak emission wavelength. A second heating source may be used 
to reduce the error induced. A modified technique of fabricating CdSe cores, cleaning 
them and subsequently coating them with ZnS has previously been reported.
89
    
For the silk fibroin coating of CdSe/ZnS quantum dots, 1,2,3, and 4 hour sonicated 
silk samples were used. No coating for the 1 hour sonicated silk was observed, whereas 
incrementally more particles were coated corresponding to 2,3, and 4 hour sonicated 
samples. The size of SF coatings were narrowly distributed. Variable size coatings may 
be required for in vivo labeling of different tissue regions. Therefore, a stoichiometry 
model corresponding to the SF coating chemistry needs to be developed in order to be 
used as a predictive tool to predict the coating thickness. 
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An obvious advantage of using this technique is that the robust structure of QDs 
fabricated using the organometallic synthesis is not altered before coating the QDs with 
SF. No ligand exchange occurs on the surface of the QDs and hence the chances of 
leaching of cadmium ions are reduced dramatically.  
The mechanism of SF coating of QD is similar to that of QD encapsulation by an 
amphiphilic diblock or triblock copolymer. However, unlike the half-life profiles of 
synthetic polymer coatings reported earlier,
19, 20
 studies have reported half-lives of SF 
coated nanoparticles to be much shorter.
90
 Although a lot of variation has been reported 
in the literature depending upon the size of the particles, site of administration and the 
concentration of the SF coated particles,
91
 the half-life typically ranges from a few hours 
to a few days. Additionally, the biocompatibility and protease susceptibility of SF have 
been demonstrated previously.
80
 Therefore, it would be safe to speculate the candidacy 
of SF coated QDs for in vivo applications. An extensive study to quantify the half-life of 
SF coated QDs in vivo can be undertaken. Specific regions of interest such as the lymph 
nodes can been labeled and the luminescence observed over definite time intervals to 
quantify the half life of these QDs.  
Unlike the technique reported earlier to achieve peptide coating of QDs using 
recombinant protein,
17
 no charge labeling of protein was required in the author’s case.  
Earlier studies have shown the use of protein coated QD assembly as sensor elements to 
sense cellular environmental properties such as pH.
17
 Use of such particles as  FRET 
sensors has also been reported.
92
 Further work is being done at our lab to investigate the 
utility of SF coated QDs for pH measurements in the biologically relevant, slightly basic, 
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pH range. Also of interest to the lab is the application of QD coated particles as FRET 
donors.
93
 
SF coated QDs were conjugated to phalloidin and streptavidin using EDC chemistry 
to endow specificity to the particles for use as labeling agent. Similar chemistry can be 
used to conjugate SF coated QDs to different anti-bodies and labeling proteins. This 
would lead to the use of SF coated QDs, for a variety of labeling applications, as 
luminescent nanoprobes.  
This simple micellar self assembly system can also be used to coat other nanoparticle 
systems. The use of SF to coat liposomal particles for drug delivery has previously been 
reported.
33
 The author speculates on the use of SF to coat different varieties of 
nanoparticles in a common system resulting in multi modal nanoparticles.
94
 
We also showed the use of SF coated QDs to label focal adhesion complex proteins. 
The role of focal adhesion complexes and specific proteins participating in the formation 
of focal adhesion complexes such as integrins has been studied earlier in the process of 
tumor invasion.
95
 The similarities between ECM degradation required for the spreading 
of metastatic tumor cells and that required for endothelial cells have also been studied.
96
 
Another line of investigation has been the role played by integrin alpha V beta III in 
tumor progression.
97
 An antagonist to this molecule (vitaxin) is in phase II clinical trial 
as of the writing of this thesis.
98
   The ability to visualize all the component proteins 
participating in the formation of focal adhesion complex would greatly enhance our 
ability to understand the dynamics at work governing the role played by FAC in tumor 
progression and potentially allow us to develop therapeutic interventions. This project is 
approachable now because of the ability of quantum dots to spectrally multiplex 
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information. SF coated QDs with different emission peaks can be all be excited 
simultaneously using a common high energy light source. This would enable the labeling 
of different components of the FAC using QDs emitting different colors and allow us to 
use a common light source for excitation. We could induce the formation of FAC using 
an AFM tip and study the FAC formation dynamics by following exciting the QDs using 
an evanescent field. Therefore, a combination of TIRF and AFM to image bio-
conjugated SF coated QDs would provide an ideal platform to conduct such a study. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
53 
 
 
 
REFERENCES 
 
(1) Dubertret, B.; David P.S.; Norris, J.; Noireaux, v.; Brivanlou, A.H.; Libchaber, A. 
Science 2002, 298, 1759-1762. 
 
(2)  Chan, W., Nie S. Science 1998, 281, 2016-2018. 
 
(3)  Bruchez, M.; Moronne M.; Gin, P.; Weiss, S.; Alivisatos, P. Science 1998, 281, 
2013-2016. 
 
(4) Stroh, M.; Zimmer J.; Duda, D.; Levchenko, T.; Cohen, K.; Brown, E.; Scadden, D.; 
Torchilin, V.; Bawendi, M.; Fukumura, D.; Jain, R.  
ature Medicine 2005, 11, (6), 
678-682. 
 
(5)  Wu, X.; Liu H.; Liu, J.; Haley, K.; Treadway, J.; Larson, J.P.; Ge, N.; Peale, F.; 
Bruchez, M.P. 
ature Biotechnology 2003, 21, 41-46. 
 
(6)  Cai, W.; Shin D.; Chen, S.K.; Gheysens, O.; Cao, Q.; Wang, S.; Gambhir, S.S.; 
Chen, X. 
ano Letters 2006, 6, (4), 669-676. 
 
(7)   Peng, Z.A.; Peng A. X. J Am. Chem. Soc. 2001, 123, 183-184. 
 
(8)  Smith, A.M.; Duan H.; Rhymer, M.; Ruan, G.; Nie, S. Physical Chemistry Chemical 
Physics 2006, 8, 3895-3903. 
 
(9)  Michalet, X.;  Pinaud F.; Bentolila, L.A.; Tsay, J.M.; Doose, S.; Li, J.J.; Sundaresan, 
G.; Wu, A.M; Gambhir, S.S.; Weiss, S. Science 2005, 307, 538-544. 
 
(10)  Pathak, S.; Choi S.; Arnheim N.;, Thompson, M.E. J. Am. Chem.  Soc. 2001, 123, 
4103-4104. 
 
(11) Kim, S.; Bawendi, M. G. J. Am. Chem Soc. 2003; 125, 14652-14653. 
 
(12) Guo, W.; Li J.; Wang, Y.A.; Peng, X. Chem. Mater. 2003, 15, 3125-3133. 
 
(13) Pinaud, F.; King D.; Moore, H.P.; Weiss, S. J. Am. Chem. Soc. 2004, 126, 6115-
6124. 
 
(14) Gao, X.; Warren C.; Nie, S. Journal of Biomedical Optics 2002, 7, (4), 532-537. 
 
(15) Pellegrino, T.; Manna L.; Kudera, S.; Liedl, T.; Koktysh, D.; Rogach, A.; et al 
ano 
Letters 2004, 4, (4), 703-707. 
 
(16) Osaki, F.; Kanamori T.; Sando, S.; Sera, T.; Aoyama, Y.  J. Am. Chem. Soc. 2004, 
126, (21), 6520-6521. 
 
54 
 
 
 
(17) Mattoussi, H.; Mauro J.; Goldman, E.; Anderson, G.; Sundar, V., et al Journal of 
American Chemcial Society 2000,122, 12142-12150. 
 
(18) Daniele, G.; Pinaud F.; Shara, W.; Wlfgang, P.; Daniela, Z.; Shimon, W. et al. 
Journal of Physical Chemistry B 2001, 105, (37), 8861-8871. 
 
(19) Gao, X.; Yuanyuan C.; Levenson, R.; Chung, L.; Nie, S.  
ature  
anotechnology 
2004, 22, (8), 969-976. 
 
(20) Ballou, B.; Lagerholn B.; Ernst, L.A; Bruchez, M.P.; Waggoner, A.S. Bioconjugate 
Chemistry 2004, 15, 79-86. 
 
(21) Clapp, A.; Goldman E.; Mattoussi, H. 
ature Protocols 2006, 1, 1258-1266. 
 
(22) Reed, M. A. Scientific American 1993, 268, (1), 118-123. 
 
(23) Ekimov, A.; Kriengol’d, F.; Kulinkin, B. Soviet Physics - Semiconductors  (English 
Translation) 1989, 23, (9), 965-6. 
 
(24) Murray, C.; Norris, D.; Bawendi M. J. Am. Chem. Soc. 1993, 115, 8706-8715. 
 
(25) Yun, Z.; Zhengtao, D.; Jiachang, Y.; Fangqiong, T.; Qun, W. Analytical 
Biochemistry 2007, 364, (2), 122-127. 
 
(26) Li, C.; Murase N. Proceedings of SPIE 2004, 5361, 150-157. 
 
(27) Chen, M.; Gao, L. Journal of the American Ceramic Society 2005, 88, (6), 1643-
1646. 
 
(28) Datta, A.; Saha, A.; Sinha, A.; Battacharya, S.; Chatterjee, S. Journal of          
Photochemistry and Photobiology B: Biology 2005, 78, (1), 69-75. 
  
(29) Dabbousi, B.; Rodriguez-Viejo, J.; Mikulec, F.; Heine, J.; Mattoussi, H.; Ober, V.;         
Jensen, K.; Bawendi, M. J. Phys. Chem. B. 1997, 101, (46), 9463-9475. 
 
(30) Mansson, A.; Sundberg, M.; Balaz, M.; Bunk, R.; Nicholls, I.; Omling, P.; Tagerud, 
S.; Montelius, L. Biochemical and Biophysical Research Communications 2004, 
314, (2), 529-534. 
 
(31) Jaiswal, J.; Mattoussi, H.; Mauro, J.M.; Simon, S.M. 
ature Biotechnology 2002, 
21, 47-51. 
 
(32) Dubertret, B.; Skourides, P.; Norris, D.J.; Noireaux, V.; Brivanlou, A.H.; 
Libchaber, A. Science 2002, 298, (5599), 1759-1762. 
 
55 
 
 
 
(33) Cheema, S.; Gobin, A.; Rhea, R.; Lopez-Berestein, G.; Newman, R.A.; Mathur, 
A.B. Pharmaceutical 
anotechnology 2007, 341, 221-229. 
 
(34) Jin, H.; Chen, J.; Karageorgiou, V.; Altman, G.H.; Kaplan, D.L. Biomaterials 2004, 
25, 1039-1047. 
 
(35) Santin, M.; Motta, A.; Freddi, G.; Cannas, G. J. Biomed Mater Res 1999, 46, 382-
389. 
 
(36) Demura, M.; Minami, M.; Asakura, T.; Cross, T.A. J. Am. Chem. Soc. 1998, 120, 
1300-1308. 
 
(37) Howe, A.; Aplin, A.; Alahari, S.K.; Juliano, R. Current Opinion in Cell Biology 
1998, 10, (2), 220-231. 
 
(38) Lukashev, M.; Werb, Z. Trends in Cell Biology 1998, 8, (11), 437-441. 
 
(39) Mizejewski, G. Proceedings of the Society for Experimental Biology and Medicine 
1999, 222, 124-138. 
 
(40) Turner S.; Sherratt, J. Journal of Theoretical Biology 2002, 216, (1), 85-100. 
 
(41) Sasisekharan, R.; Shriver, Z.; Venkataraman, G.; Narayanasami, U. 
ature Reviews 
Cancer 2002, 2, 521-528. 
 
(42) Alberts, B.;  Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter. P. Molecular 
Biology of the Cell 2008, 4, 1071-1083. 
 
(43) Chen, C.; Alonso, J.; Ostuni, E.; Whitesides, G.; Ingber, D.E. Biochemical and 
Biophysical Research Communications 2003, 307, (2), 355-361. 
 
(44) Zameer, E.; Geiger, B. Journal of Cell Science 2001, 114, 3583-3590. 
 
(45) Zaldel-Bar, R.; Cohen, M.; Addadi, L.; Geiger, B. Biochemical Society 
Transactions 2004, 32, (3), 416-420. 
 
(46) Zimmerman, P.; David, G. The FASEB journal 1999, 13, S91-S100. 
 
(47) Woods, A.; Couchman, J. Trends in Cell Biology 1998, 8, (5), 189-192. 
 
(48) Couchman, J.; Woods, A. Journal of Cellular Biochemistry 1995, 61, (4), 578-584. 
 
(49) Nikolovski, J.; Mooney, D. Biomaterials 2000, 21, (20), 2025-2032. 
 
(50) Bloemen, P.; Henricks, J.; Bloois, L.; Tweel, M.; Bloem, A.C.; Nijkamp, F.P.; 
Crommelin, F.P; Storm, G. FEBS Letters 1995, 357, (2), 140-144. 
56 
 
 
 
 
(51) Stephens, D.; Allan, V. J. Science 2003, 300, 82-86. 
 
(52) Axelrod, D. J. Cell Biol. 1981, 89, 141-145. 
 
(53) Sund, S.; Axelrod, D. Biophysics. J. 2000; 79, 1655-1669. 
 
(54) Sako, Y.; Minoguchi, S.; Yanagida, T. 
ature Cell Biology 2000, 2, 168-172. 
 
(55) Kuhn, J.; Pollard, T. Biophys. J. 2005, 88, (2), 1387-1402. 
 
(56) Weiss, R.; Balakrishna, K.; Smith, B.A.; McConnell, H.M. The Journal of 
Biological Chemistry 1982, 257, (11), 6440-6445. 
 
(57) Lang, T.; Wacker, I.; Wunderlich, I.; Rohrbach, A.; Giese, G.; Soldati, T.; Almers, 
W. Biophysical Journal 2000, 78, (6), 2863-2877. 
 
(58) Vale, R.; Funatsu, A.; Pierce, D.; Romberg, L.; Harada, Y.; Yanagida, T. 
ature 
1996, 380, 451-453. 
 
(59) Dickson, R.; Norris, D.; Tzeng, T.; Moerner, W.E. Science 1996, 274, (5289), 966-
969. 
 
(60) Ha, T.; Ting, A.; Liang, J.; Caldwell, W.B.; Deniz, A.; Chemla, D.D.; Schultz, P.G.; 
Weiss, S. Proc. 
atl. Acad. Sc. 1999, 96, (3), 893-898. 
 
(61) Han, W.; Ng, Y.; Axelrod, D.; Levitan, E.S. Proc. 
atl Acad Sci 1999, 96, (25), 
14577-14582. 
 
(62) Rohrbach, A. Biophys. J. 2000, 78, (5), 2641-2654. 
 
(63) Lagerholm, B.; Starr, T.; Volovyk, Z.N.; Thompson, N.L. Biochemistry 2000, 39, 
(8), 2042-2051. 
 
(64) Sund, S.; Swanson, J.; Axelrod, D. Biophys. J. 1999, 77, (4), 2266-2283. 
 
(65) Mathur, A.; Truskey, G.; Reichert, W. M. Biophycal J. 2000; 78, 1725-1735. 
 
(66) Wang, M.; Axelrod, D. Developmental Dynamics 2005, 20, (1), 29-40. 
 
(67) Omann, G.; Axelrod, D. Biophysical Journal 1996, 71, (5), 2885-2891. 
 
(68) Bining, G.; Quate, C.; Gerber, C. Physical Review Letters 1986, 56, (9), 930-936. 
 
(69) Alessandrini, A.; Facci, P. Measurement Science and Technology 2005, 16, R65-
R92. 
57 
 
 
 
 
(70) Matzke, R.;  Jacobson, K.; Radmacher, M. 
ature Cell Biology 2001, 3, 607-610. 
 
(71) Raab, A.; Han, W.; Badt, D.; Smith-Gill, S.J.; Lindsay, S.M.; Schindler, H.; 
Hinterdorfer, P. 
ature Biotechnology 1999, 17, 901-905. 
 
(72) Rotsch, C.; Radmacher, M. Biophycal J. 2000; 78, 520-535. 
 
(73) Trache, A.; Trzekiakowski, J.; Gardiner, L.; Sun, Z.; Muthuchamy, M.; Guo, M.; 
Yuan, S.; Meininger, G.A. Biophys J  2005, 89, 2888-2898. 
 
(74) Krautbauer, R.; Rief, M.; Gaub, H. E. 
anoletters 2003; 3, 493-496. 
 
(75) Muller, D.; Baumeister, W.; Engel, A. Proc. 
atl. Acad. Sci 1999; 96, 13170-
13174. 
 
(76) Fisher, T.; Oberhauser, A. F.; Carrion-Vazquez, M.; Marszalek, P. E.; Fernandez, J. 
M. Trends in Biochemical Sciences 1999, 24, (10), 379-384. 
 
(77) Goldmann, W. H.; Galneder, R.; Ludwig, M.; Xu, W.; Adamson, E. D.; Wang, N.; 
Ezzell, R. M. Experimental Cell Research 1998, 239, (2), 235-242. 
 
(78) Trache, A.; Meininger, G. Journal of Biomedical Optics 2005, 10, (6), 64023-
64040. 
 
(79) Sarkar, A.; Robertson, R.; Fernandez, J.M. P
AS 2004, 101, (35), 12882-12886. 
 
(80) Gobin, A.S.; Froude, V.; Mathur, A.B. Journal of Biomedical Materials Research 
Part A 2005, 74A, (3), 465-473. 
 
(81) Graareck, Z.; Gergely, J. Analytical Biochemistry 1990, 185, (1), 131-135. 
 
(82) Daniels, G. M.; Amara, S. G.; Susan, G. A. Methods in Enzymology 1998; 296, 307-
318. 
 
(83) Kortan, A.R.; Hull, R.; Opila, R.L.; Bawendi, M.G.; Steigerwald, M.L.; Carroll, 
P.J.; Brus, L.E. J. Am. Chem. Soc. 1990, 112, (4), 1327-1332. 
 
(84) Dobb, M.G.; Fraser, R.; Macrae, T.P. The Journal of Cell Biology 1967, 32, 289-
295. 
 
(85) Chen, X.; Knight, D.; Shao, Z.; Vollrath, Z. Polymer 2001, 42, (25), 09969-09974. 
 
(86) Weber, P.; Ohlendorf, D.; Wendoloski, J.J.; Salemme, F.R. Science 1989, 243, 
(4887), 85-88. 
 
58 
 
 
 
(87) Wieland, T.; Vries, J.; Schafer, A.; Faulstich, A. FEBS Letters 1975, 54, (1), 73-75. 
 
(88) Mitchell, G.P.; Mirkin, C.; Letsinger, R. J. Am. Chem. Soc. 1999, 121, 8122-8123. 
 
(89) Murray, C.B.; Kagan, C.; Bawendi, M.G. Annual Review of Material Science 2000, 
30, 545-610. 
 
(90) Zhang, Y.; Xia, Y.; Shen, W.; Mao, J.P.; MinZha, X.; Shirai, K.; Kiguchi, K. 
Journal of Biomedical Materials Research Part B: Applied Biomaterials 2006, 79B, 
(2), 275-283. 
 
(91) Shammakhi, N; Ndreu, A.; Yang, Y.; Ylikauppila, Y.; Nikkola, L.; Hasirci, V. The 
Journal of Craniofacial Surgery 2007, 18, (1), 3-17. 
 
(92) Sapsford, K.E.; Medintz, I.; Golden, J.P.; Deschamps, J.R.; Uyeda,H.; Mattoussi, H. 
Langmuir 2004, 20, 7720-7728. 
 
(93) Meissner, K.E.; Sun, Z.; Nathwani, B.; Needham, C.; Beckham, R.; Everett, W.N.; 
Fan, X.; Cote, G.; Meininger, G.A. Proceedings of SPIE 2008, 6863, (02). 
 
(94) Ferrari, M. 
ature Reviews Cancer 2005, 5, (3), 161-171. 
 
(95) Keshet, E.; Ben, S. J. Clin. Invest. 1999, 104, (11), 1497-1501. 
 
(96) Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cell 1991, 64, (2), 327-336. 
 
(97) Eliceiri, B. P.; Klemke, R.; Stromblad, S.; Cheresh, D. A. The Journal of Cell 
Biology 1998; 140, 1255-1263. 
 
(98) Elicieri, B.; Cheresh, D. J. Clin. Invest. 1999, 103, (9), 1227-1230. 
 
 
 
 
 
 
59 
 
 
 
 
APPENDIX 
 
Photon Technologies International 
 
Figure A1. Top view of the Quantamaster Fluorometer used for this project.  
Key to Figure 
1 Flash lamp housing 
2 Adjustable slits 
3 Excitation monochromator 
4 Excitation correction unit 
5 Sample compartment 
6 Baffle 
7 Filter holders 
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8 Excitation/emission optics 
9 Cuvette holder 
10 Emission port shutter 
11 Emission monochromator 
12 Gated PMT detector 
Dimension 
(excluding computer and electronics)  
System overall:  32 x 26 inches or 82 x 67 cm 
Procedure for biotinylating proteins
71
 
1. Remove the vial of Sulfo-NHS-Biotin from freezer and equilibrate it 
to room temperature before opening in Step 3. 
2. Dissolve 1-10 mg protein in 0.5-2 ml of phosphate buffered saline 
(PBS) according to the calculation made. 
3. Immediately before use, prepare a 10 mM Sulfo-NHS-Biotin solution 
by dissolving 2.2 mg in 500 micro liters of ultrapure water. 
4. Add the appropriate volume of Sulfo-NHS-Biotin solution. 
5. Incubatereaction on ice for two hours or at room temperature for 30-
60 minutes.  
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